99 devices · GMDN 60649
S100 protein in vitro diagnostic (IVD) antibody tests detect specific S100 protein markers in clinical samples, such as blood or tissue. These devices help diagnose or monitor conditions like brain injuries, infections, or inflammatory diseases by identifying elevated S100 levels, which may indicate tissue damage or neurological disorders.
These tests are typically regulated as IVDs, with classification depending on their intended use—such as risk stratification or diagnostic confirmation. They may be supplied as kits, reagents, or pre-packaged assays, often requiring laboratory processing or automated platforms for accurate results.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.